Selected article for: "asthma development and high risk"

Author: Jartti, Tuomas; Smits, Hermelijn H.; Bønnelykke, Klaus; Bircan, Ozlem; Elenius, Varpu; Konradsen, Jon R.; Maggina, Paraskevi; Makrinioti, Heidi; Stokholm, Jakob; Hedlin, Gunilla; Papadopoulos, Nikolaos; Ruszczynski, Marek; Ryczaj, Klaudia; Schaub, Bianca; Schwarze, Jürgen; Skevaki, Chrysanthi; Stenberg-Hammar, Katarina; Feleszko, Wojciech
Title: Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments
  • Document date: 2018_11_25
  • ID: 4svg09dt_3
    Snippet: Bronchiolitis presents a huge clinical burden. Depending on the definitions, the prevalence of bronchiolitis has been between 18% and 32% in the first and 9% and 17% in the second year of life. 2, 3 At the same time, the overall risk of recurrent wheezing and asthma is 70% before school-age and 50% during school years. 1, 4 However, patient characteristics and the risk of asthma strongly vary inside the bronchiolitis cohort thus revealing differe.....
    Document: Bronchiolitis presents a huge clinical burden. Depending on the definitions, the prevalence of bronchiolitis has been between 18% and 32% in the first and 9% and 17% in the second year of life. 2, 3 At the same time, the overall risk of recurrent wheezing and asthma is 70% before school-age and 50% during school years. 1, 4 However, patient characteristics and the risk of asthma strongly vary inside the bronchiolitis cohort thus revealing different disease entities, some of which have a markedly high risk of subsequent asthma development.

    Search related documents:
    Co phrase search for related documents
    • asthma development and clinical burden: 1
    • asthma development and disease entity: 1, 2
    • asthma development and life second year: 1, 2
    • asthma development and recurrent wheezing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • asthma development and school age: 1, 2, 3, 4, 5
    • asthma recurrent wheezing and bronchiolitis cohort: 1, 2
    • asthma recurrent wheezing and recurrent wheezing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • asthma recurrent wheezing and school age: 1, 2
    • asthma risk and bronchiolitis cohort: 1, 2, 3
    • asthma risk and bronchiolitis prevalence: 1
    • asthma risk and clinical burden: 1, 2
    • asthma risk and disease entity: 1, 2
    • asthma risk and life second year: 1
    • asthma risk and overall risk: 1, 2, 3, 4
    • asthma risk and recurrent wheezing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • asthma risk and school age: 1, 2, 3, 4, 5, 6, 7, 8
    • bronchiolitis cohort and recurrent wheezing: 1, 2
    • bronchiolitis cohort and school age: 1
    • bronchiolitis prevalence and recurrent wheezing: 1